A Durham company is making progress on a gene therapy targeting hepatitis B. STORY HIGHLIGHTS Precision BioSciences received approval for hepatitis B gene editing trial. Moldova approved the ...

The company has submitted Clinical Trial Applications to initiate a Phase 1 study for PBGENE-HBV, a potential cure for chronic hepatitis B. This step is crucial as Precision BioSciences aims to ...

Bright Minds Biosciences announced a non-brokered private placement with expected gross proceeds of $35 million. The company's stock is currently trading with a session volume of about 10.6 million.

SHREVEPORT, La. – A career in health science is much more than becoming a doctor or nurse. Tomorrow and Saturday, high school and college students can see what other careers are available ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Please use one of the following formats to cite this article in your essay, paper or report: APA Axol Bioscience Ltd. (2024, October 22). Axol Bioscience acquires Phenocell to advance human ...

THE WEEK’S MOST POPULAR CURRENT R&B/HIP-HOP SONGS ACROSS ALL GENRES, RANKED BY STREAMING ACTIVITY DATA BY ONLINE MUSIC SOURCES TRACKED BY LUMINATE, RADIO AIRPLAY AUDIENCE IMPRESSIONS AS MEASURED ...

Molson Coors Beverage Co. Cl A 0.37% $12.47B Molson Coors Beverage Co. Cl B 1.58% $12.47B ...

DURHAM, N.C. — DURHAM, N.C. — Precision BioSciences Inc. (DTIL) on Monday reported a loss of $16.4 million in its third quarter. The Durham, North Carolina-based company said it had a loss of ...

Oct. 31, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI) a data-first generative AI drug creation company, and Twist Bioscience Corporation (NASDAQ: TWST) a company enabling customers to ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq ... gene editing program designed to cure chronic hepatitis B by eliminating cccDNA, the key source of replicating hepatitis ...

Luminal B breast cancer is positive for estrogen and sometimes progesterone receptors. It may be positive or negative for epidermal growth factor receptor 2 and has high levels of the protein Ki-67.